Despite the downgrades, 29 out of the 39 analysts who cover the stock have a “buy” rating, while only three have a “sell” rating. Seven have a “hold” recommendation.
Despite the downgrades, 29 out of the 39 analysts who cover the stock have a “buy” rating, while only three have a “sell” rating. Seven have a “hold” recommendation.